HIT

MKT CAP:$81M

Health In Tech, Inc.

Market Cap

$81M

Technology·Software - Application·🇺🇸 United States·NASDAQ

Technology·Software App·🇺🇸·NASDAQ

Stock Price

$1.65-$0.10 (-5.71%)

Apr 22, 2026

Company Details

Health In Tech, Inc. operates as an insurance technology platform company. The company offers reference-based pricing, group insurance captives, community health plans, and association health programs for small businesses; and enhance do it...

CEO

Tim Johnson

IPO Date

Dec 23, 2024

Website

healthintech.com

Key Metrics TTM

Revenue

$31M

+55.1% YoY

Net Income

$1M

EPS (Diluted)

$0.03

Free Cash Flow

$2M

Revenue / Share

$0.52

Gross Margin

67.1%

Operating Margin

4.5%

Net Margin

4.7%

FCF Margin

5.0%

P/S

2.6x

P/E

56.2x

Earnings Reports

FY 2025

Mar 25, 2026

$33M+71.0%EPS $0.02

Q3 2025

Nov 12, 2025

$8M+90.4%EPS $0.01

Q2 2025

Aug 8, 2025

$9M+86.2%EPS $0.01

Q1 2025

May 9, 2025

$8M+56.4%EPS $0.01

FY 2024

Mar 17, 2025

$19MEPS $0.01

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 23	$5M	$4M	$518.1K
Q4 23	$5M	$4M	$1M
Q1 24	$5M	$4M	$332.4K
Q2 24	$5M	$4M	$534.9K
Q3 24	$4M	$3M	$438.9K
Q4 24	$5M	$4M	-$316.3K
Q1 25	$8M	$5M	$480.7K
Q2 25	$9M	$6M	$725.1K
Q3 25	$8M	$5M	$493.5K

Valuation

Quarter	P/S	P/E
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	13.4x	149.6x
Q3 24	13.9x	151.8x
Q4 24	14.9x	432.2x
Q1 25	1.6x	34.3x
Q2 25	1.9x	36.5x
Q3 25	6.5x	138.2x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q3 23	$571.6K	$337.0K
Q4 23	-$405.6K	-$683.2K
Q1 24	-$680.2K	-$813.6K
Q2 24	$1M	$1M
Q3 24	$2M	$2M
Q4 24	-$531.2K	-$1M
Q1 25	$527.4K	-$176.1K
Q2 25	$1M	$571.4K
Q3 25	$674.0K	$2M

Capital Expenditures

Quarter	CapEx
Q3 23	$234.6K
Q4 23	$277.6K
Q1 24	$133.4K
Q2 24	$94.0K
Q3 24	$67.3K
Q4 24	$606.1K
Q1 25	$703.5K
Q2 25	$909.9K
Q3 25	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 24	-14.9%	-14.8%
Q4 24	-6.0%	+38.8%
Q1 25	+56.4%	+57.2%
Q2 25	+86.2%	+92.2%
Q3 25	+90.4%	+98.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$0	0.0%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$493.2K	6.2%
Q2 25	$708.0K	7.6%
Q3 25	$292.6K	3.4%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q3 23	$501.1K	$2M	$968.0K
Q4 23	$673.4K	$1M	$873.9K
Q1 24	$760.2K	$2M	$1M
Q2 24	$701.6K	$2M	$974.5K
Q3 24	$718.4K	$2M	$508.5K
Q4 24	$633.7K	$3M	$632.1K
Q1 25	$537.7K	$3M	$1M
Q2 25	$582.6K	$4M	$1M
Q3 25	$235.8K	$3M	$962.6K

Rule of 40

Quarter	Rev Growth %	EBITDA Margin %	Rule of 40
Q3 23	—	12.5%	—
Q4 23	—	30.9%	—
Q1 24	—	9.6%	—
Q2 24	—	14.0%	—
Q3 24	-14.9%	15.9%	1.0
Q4 24	-6.0%	0.5%	-5.5
Q1 25	56.4%	10.2%	66.6
Q2 25	86.2%	10.4%	96.6
Q3 25	90.4%	9.6%	100.0

Rule of 40

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 23	$2M	$0	$2M
Q1 24	$1M	$0	$1M
Q2 24	$2M	$0	$2M
Q3 24	$2M	$0	$2M
Q4 24	$8M	$0	$8M
Q1 25	$8M	$0	$8M
Q2 25	$8M	$0	$8M
Q3 25	$8M	$0	$8M
Q4 25	$8M	$0	$8M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 23	54M	—	—
Q4 23	54M	0.0%	—
Q1 24	54M	0.0%	—
Q2 24	54M	0.0%	—
Q3 24	54M	0.0%	0.0%
Q4 24	54M	0.0%	0.0%
Q1 25	57M	+5.4%	+5.4%
Q2 25	56M	-2.4%	+2.9%
Q3 25	59M	+5.6%	+8.7%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	$9.8K	500
Q1 25	$16.0K	500
Q2 25	$18.6K	500
Q3 25	$17.0K	500

Revenue / Employee